Marksans Pharma Expands Horizons: Nova Partnership Unlocks Australian Market Potential

Marksans Pharma is set to market its products in Australia through Nova Pharmaceuticals, leveraging its 100+ Marketing Authorizations in the region. The company's Goa facility, approved by the Australian TGA, US FDA, and UK MHRA, specializes in solid dosage forms and capsules. This strategic positioning enhances Marksans' global presence, particularly in OTC segments. The company's robust product portfolio spans major therapeutic segments, with manufacturing facilities in India, the US, and the UK.

 

Source: NSE, BSE, Marksans Pharma